Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (121-130 of 375) with videos related to

Pageof 38
Sort By:
Cancers|February 25, 2022
Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert PanelGiampaolo Bianchini, Grazia Arpino, Laura Biganzoli, et al.
Expert Review of Anticancer Therapy|May 22, 2018
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospectsMariana Brandão, Noam F Pondé, Francesca Poggio, et al.
Current Opinion in Oncology|August 21, 2025
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectivesLuca Arecco, Gabriella Gentile, Riccardo Gerosa, et al.
La Radiologia Medica|December 19, 2022
Muscle mass loss in breast cancer patients of reproductive age (≤ 45 years) undergoing neoadjuvant chemotherapyFederica Rossi, Matteo Lambertini, Nicole Brunetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With CancerMatteo Lambertini, Tommaso Falcone, Joseph M Unger, et al.
Targeted Oncology|September 14, 2022
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New ResearchMireille Langouo Fontsa, Marco Maria Aiello, Edoardo Migliori, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2022
Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancyRichard A Anderson, Matteo Lambertini, Peter S Hall, et al.
Breast Cancer Research : BCR|February 17, 2019
Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancerBastien Nguyen, David Venet, Matteo Lambertini, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Interview ABC7: Bridging the GapRachel Wuerstlein, Maria João Cardoso, Joana M Ribeiro, et al.
Therapeutic Advances in Medical Oncology|February 20, 2025
Efficacy of goserelin in ovarian function suppression and preservation for pre- and perimenopausal breast cancer patients: a systematic reviewNan Chen, Daniella Audi Blotta, Hee Jeong Kim, et al.
Pageof 38

Showing results (121-130 of 375) with videos related to

Sort By:
Pageof 38
Cancers|February 25, 2022
Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert PanelGiampaolo Bianchini, Grazia Arpino, Laura Biganzoli, et al.
Expert Review of Anticancer Therapy|May 22, 2018
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospectsMariana Brandão, Noam F Pondé, Francesca Poggio, et al.
Current Opinion in Oncology|August 21, 2025
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectivesLuca Arecco, Gabriella Gentile, Riccardo Gerosa, et al.
La Radiologia Medica|December 19, 2022
Muscle mass loss in breast cancer patients of reproductive age (≤ 45 years) undergoing neoadjuvant chemotherapyFederica Rossi, Matteo Lambertini, Nicole Brunetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With CancerMatteo Lambertini, Tommaso Falcone, Joseph M Unger, et al.
Targeted Oncology|September 14, 2022
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New ResearchMireille Langouo Fontsa, Marco Maria Aiello, Edoardo Migliori, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2022
Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancyRichard A Anderson, Matteo Lambertini, Peter S Hall, et al.
Breast Cancer Research : BCR|February 17, 2019
Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancerBastien Nguyen, David Venet, Matteo Lambertini, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Interview ABC7: Bridging the GapRachel Wuerstlein, Maria João Cardoso, Joana M Ribeiro, et al.
Therapeutic Advances in Medical Oncology|February 20, 2025
Efficacy of goserelin in ovarian function suppression and preservation for pre- and perimenopausal breast cancer patients: a systematic reviewNan Chen, Daniella Audi Blotta, Hee Jeong Kim, et al.
Pageof 38